Aprotinin - Haemaprot : Troikaa Pharmaceuticals Limited. Ahmedabad, India

-ISO 9001:2000

Orphan Drugs

Overlooking the profit motive & to make India self sufficient, we manufacture several orphan drugs which do not have adequate market potential, but are essential for the healthcare needs of the medical profession.

Haemaprot

Haemaprot is indicated for prophylactic use to reduce pre-operative blood loss and the need for blood transfusion in patients undergoing CardioPulmonary Bypass (CPB) in the course of coronary artery bypass graft surgery.

The effects of Aprotinin use in CPB involve a reduction in systemic inflammatory response, which translates into a decreased need for allogeneic blood transfusions, reduced bleeding and decreased mediastinal reexploration for bleeding.

Corporate Philosophy

Troikaa Pharmaceuticals Limited is a young pharmaceutical company, which has acquired a reputation of an innovative company, over the years. We have been steadfastly sowing the basics of Innovation, Quality and Service to reap excellence.